G17D (p.Gly17Asp) variant of GRIA2 (Glutamate receptor 2)
G17D (p.Gly17Asp) in GRIA2 (Glutamate receptor 2) is a protein-truncating change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.66 / 1. The record also includes population frequency data, published literature, and structural context.
G17D (p.Gly17Asp) variant details
- p.Gly17Asp
- gnomAD 4-157221088-TG-T
- Frameshift
- Variant Prioritization Score for Impact Estimate 0.66
- CADD 29.70
- Population evidence available
- Structural context available
- Literature evidence available